Unveiling the endogenous CRISPR-Cas system in Pseudomonas aeruginosa PAO1
- PMID: 39739718
- PMCID: PMC11687729
- DOI: 10.1371/journal.pone.0312783
Unveiling the endogenous CRISPR-Cas system in Pseudomonas aeruginosa PAO1
Abstract
Multidrug resistance in Pseudomonas aeruginosa, a high-priority pathogen per the World Health Organization, poses a global threat due to carbapenem resistance and limited antibiotic treatments. Using the bioinformatic tools CRISPRCasFinder, CRISPRCasTyper, CRISPRloci, and CRISPRImmunity, we analyzed the genome of P. aeruginosa PAO1 and revealed an orphan CRISPR system, suggesting it may be a remnant of a type IV system due to the presence of the DinG protein. This system comprises two CRISPR arrays and noteworthy DinG and Cas3 proteins, supporting recent evidence about the association between type IV and I CRISPR systems. Additionally, we demonstrated a co-evolutionary relationship between the orphan CRISPR system in P. aeruginosa PAO1 and the mobile genetic element and prophages identified. One self-targeting spacer was identified, often associated with bacterial evolution and autoimmunity, and no Acr proteins. This research opens avenues for studying how these CRISPR arrays regulate pathogenicity and for developing alternative strategies using its endogenous orphan CRISPR system against carbapenem-resistant P. aeruginosa strains.
Copyright: © 2024 Delgado-Nungaray et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interest exist.
Figures

Similar articles
-
Requirements for Pseudomonas aeruginosa Type I-F CRISPR-Cas Adaptation Determined Using a Biofilm Enrichment Assay.J Bacteriol. 2016 Oct 21;198(22):3080-3090. doi: 10.1128/JB.00458-16. Print 2016 Nov 15. J Bacteriol. 2016. PMID: 27573013 Free PMC article.
-
Phylogenetic Distribution of CRISPR-Cas Systems in Antibiotic-Resistant Pseudomonas aeruginosa.mBio. 2015 Nov 24;6(6):e01796-15. doi: 10.1128/mBio.01796-15. mBio. 2015. PMID: 26604259 Free PMC article.
-
Analysis of direct repeats and spacers of CRISPR/Cas systems type I-F in Brazilian clinical strains of Pseudomonas aeruginosa.Mol Genet Genomics. 2019 Oct;294(5):1095-1105. doi: 10.1007/s00438-019-01575-7. Epub 2019 May 16. Mol Genet Genomics. 2019. PMID: 31098740 Review.
-
Exploring the success of Brazilian endemic clone Pseudomonas aeruginosa ST277 and its association with the CRISPR-Cas system type I-C.BMC Genomics. 2020 Mar 23;21(1):255. doi: 10.1186/s12864-020-6650-9. BMC Genomics. 2020. PMID: 32293244 Free PMC article.
-
Genome editing using CRISPR, CAST, and Fanzor systems.Mol Cells. 2024 Jul;47(7):100086. doi: 10.1016/j.mocell.2024.100086. Epub 2024 Jun 21. Mol Cells. 2024. PMID: 38909984 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources